Pfizer to disclose payments of $500 to healthcare prescribersBMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b689 (Published 18 February 2009) Cite this as: BMJ 2009;338:b689
- Janice Hopkins Tanne
- 1New York
Pfizer, the world’s largest drug company, announced on 9 February that it would begin disclosing payments of $500 (£350; €390) or more a year to doctors and others who prescribe drugs.
The disclosures will include payments to practising US physicians, as well as principal investigators, major academic institutions, and research sites for clinical research, the company said. Pfizer said it would be the first biopharmaceutical company to disclose payments for conducting phase I-IV clinical trials as well as payments for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial